Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.2987 | 11 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.26559 | 11 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.25133 | 10 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.24007 | 11 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.4528 | 21 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.25199 | 8 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.25375 | 9 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.29807 | 13 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.24785 | 11 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.24358 | 10 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.23889 | 10 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.51639 | 23 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.25551 | 10 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.24147 | 10 |